Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
41.07
+0.92 (2.29%)
At close: Mar 9, 2026, 4:00 PM EDT
41.36
+0.29 (0.71%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $3.23 billion as of March 9, 2026. Its market cap has increased by 179.86% in one year.
Market Cap
3.23B
Enterprise Value
2.47B
1-Year Change
179.86%
Ranking
Category
Stock Price
$41.07
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $3.23B, an increase of 2,787.77%. That is a compound annual growth rate of 40.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.15B | 24.06% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 3.50B |
| Xenon Pharmaceuticals | 3.49B |
| NewAmsterdam Pharma Company | 3.43B |
| Alumis | 3.35B |
| Denali Therapeutics | 3.12B |
| Tarsus Pharmaceuticals | 3.12B |
| Edgewise Therapeutics | 2.98B |
| Arcutis Biotherapeutics | 2.98B |